Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.
Sumnall HR, Jerome L, Doblin R, Mithoefer MC. Sumnall HR, et al. Psychopharmacology (Berl). 2004 Jan;171(2):229-30. doi: 10.1007/s00213-003-1599-3. Epub 2003 Nov 21. Psychopharmacology (Berl). 2004. PMID: 14634709 No abstract available.
Altered states: the clinical effects of Ecstasy.
Cole JC, Sumnall HR. Cole JC, et al. Among authors: sumnall hr. Pharmacol Ther. 2003 Apr;98(1):35-58. doi: 10.1016/s0163-7258(03)00003-2. Pharmacol Ther. 2003. PMID: 12667887 Review.
The BDI of the beholder.
Cole JC, Sumnall HR. Cole JC, et al. Among authors: sumnall hr. J Psychopharmacol. 2002 Mar;16(1):103. doi: 10.1177/026988110201600109. J Psychopharmacol. 2002. PMID: 11949766 No abstract available.
What is a dose of ecstasy?
Cole JC, Sumnall HR, Wagstaff GF. Cole JC, et al. Among authors: sumnall hr. J Psychopharmacol. 2002 Jun;16(2):189-90. doi: 10.1177/026988110201600211. J Psychopharmacol. 2002. PMID: 12095080 No abstract available.
67 results